JPH07138248A - Ester compound from retinoid and ascorbic acid and derivative therefrom and their production - Google Patents
Ester compound from retinoid and ascorbic acid and derivative therefrom and their productionInfo
- Publication number
- JPH07138248A JPH07138248A JP5291801A JP29180193A JPH07138248A JP H07138248 A JPH07138248 A JP H07138248A JP 5291801 A JP5291801 A JP 5291801A JP 29180193 A JP29180193 A JP 29180193A JP H07138248 A JPH07138248 A JP H07138248A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- compound
- salt
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- -1 Ester compound Chemical class 0.000 title description 39
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title description 32
- 229960005070 ascorbic acid Drugs 0.000 title description 15
- 239000011668 ascorbic acid Substances 0.000 title description 7
- 235000010323 ascorbic acid Nutrition 0.000 title description 7
- 150000004492 retinoid derivatives Chemical class 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 43
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims abstract description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 9
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 125000005843 halogen group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 239000002211 L-ascorbic acid Substances 0.000 description 8
- 235000000069 L-ascorbic acid Nutrition 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005071 nonynyl group Chemical group C(#CCCCCCCC)* 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004291 polyenes Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000001444 retinoyl group Chemical group O=C([*])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000005040 tridecenyl group Chemical group C(=CCCCCCCCCCCC)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、新規化合物である、レ
チノイドとアスコルビン酸からなるエステル化合物およ
びその誘導体ならびにそれらの製造法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel compound, an ester compound consisting of retinoid and ascorbic acid, a derivative thereof and a process for producing them.
【0002】[0002]
【従来の技術】これまで、アスコルビン酸、およびレチ
ノイドの誘導体については各種化合物が報告されている
(特開昭60−130582号、特開昭61−2639
69号、ザ・レチノイド(The retinoids)第1巻、7
〜145頁(1984)など)。しかし、脂溶性ビタミン
であるレチノイド類と水溶性ビタミンであるアスコルビ
ン酸のエステル化合物およびその誘導体は報告されてい
ない。2. Description of the Related Art Various compounds have been reported as derivatives of ascorbic acid and retinoids.
(JP-A-60-130582, JP-A-61-2639
No. 69, The Retinoids Volume 1, 7
Pp. 145 (1984)). However, ester compounds and derivatives of retinoids, which are fat-soluble vitamins, and ascorbic acid, which is a water-soluble vitamin, have not been reported.
【0003】[0003]
【発明が解決しようとする課題】レチノイドは、ビタミ
ンAおよびその関連化合物である。ビタミンAは、動物
の成長、正常な視覚の維持、上皮組織の正常な分化調
節、免疫機構の維持、抗腫瘍効果等が認められている脂
溶性のビタミンである。しかし、ポリエン骨格をもつた
め空気、酸、熱、金属イオンなどに非常に敏感で不安定
である。一方、アスコルビン酸は、水溶性ビタミンであ
るビタミンCであり、強い還元力を示し、コラーゲンの
生合成、チロシンの代謝、カテコールアミンの生合成、
生体異物の解毒、脂質代謝系の関与などが、認められる
物質である。そこで、レチノイドとアスコルビン酸から
なるエステル化合物およびその誘導体は、ビタミンAお
よびビタミンCの性質、活性を合わせ持つ物質としての
期待が持たれ、さらには、ビタミンAおよびビタミンC
に認められなかった新たな生理活性効果が期待される。Retinoids are vitamin A and its related compounds. Vitamin A is a fat-soluble vitamin that has been recognized for its growth in animals, maintenance of normal vision, normal regulation of epithelial tissue differentiation, maintenance of immune system, antitumor effect, and the like. However, since it has a polyene skeleton, it is very sensitive and unstable to air, acid, heat, metal ions, etc. On the other hand, ascorbic acid is vitamin C, which is a water-soluble vitamin, and has a strong reducing power, and it has biosynthesis of collagen, metabolism of tyrosine, biosynthesis of catecholamine,
Detoxification of xenobiotics and involvement of lipid metabolism system are recognized substances. Therefore, an ester compound composed of retinoid and ascorbic acid and its derivative are expected to be substances having both the properties and activities of vitamin A and vitamin C, and further, vitamin A and vitamin C.
It is expected to have a new physiologically active effect that was not observed in.
【0004】[0004]
【課題を解決するための手段】かかる事情に鑑み、本発
明者らは鋭意研究を行った結果、新規化合物である、レ
チノイドとアスコルビン酸からなるエステル化合物およ
びその誘導体の創製に成功し、本発明を完成するに至っ
た。すなわち、本発明は、(1)式(I):In view of the above circumstances, the present inventors have conducted diligent research, and as a result, succeeded in creating a novel compound, an ester compound consisting of retinoid and ascorbic acid, and a derivative thereof, and the present invention Has been completed. That is, the present invention provides formula (I):
【0005】[0005]
【化7】 [Chemical 7]
【0006】[式中、R1は、[Wherein R 1 is
【0007】[0007]
【化8】 [Chemical 8]
【0008】(X1およびX2は、同一または異なっ
て、アルキル基、ヒドロキシアルキル基、またはカルボ
キシル基を示す。)を示し、R2、R3およびR4は、同
一または異なって水素または有機残基を示す。また、R
3およびR4が一緒になってアセタールまたはケタールを
形成していてもよい。さらに、nは1〜10であり、
[ ]内は、すべての立体異性体を含む。]で表される化
合物またはその塩、(2)R2、R3およびR4が水素で
ある上記(1)記載の化合物またはその塩、(3)
R2、R3およびR4が、それぞれ置換されていてもよい
アルキル基、シクロアルキル基、アルケニル基、アルキ
ニル基、アラルキル基、アリール基、ヘテロ環基または
アシル基から選ばれる有機残基である上記(1)記載の
化合物またはその塩、(4)X1およびX2が、同一また
は異なって、メチル基、ヒドロキシメチル基またはカル
ボキシル基である上記(1)記載の化合物またはその
塩、(5)R1が(X 1 and X 2 are the same or different and each represents an alkyl group, a hydroxyalkyl group or a carboxyl group), and R 2 , R 3 and R 4 are the same or different and are hydrogen or organic. Indicates a residue. Also, R
3 and R 4 may together form an acetal or ketal. Further, n is 1-10,
[] Includes all stereoisomers. ] Or a salt thereof, (2) a compound or salt thereof according to the above (1), wherein R 2 , R 3 and R 4 are hydrogen, (3)
R 2 , R 3 and R 4 are each an organic residue selected from an optionally substituted alkyl group, cycloalkyl group, alkenyl group, alkynyl group, aralkyl group, aryl group, heterocyclic group or acyl group. The compound or salt thereof described in (1) above, (4) X 1 and X 2 are the same or different and each is a methyl group, a hydroxymethyl group or a carboxyl group, or a salt thereof (5) ) R 1 is
【0009】[0009]
【化9】 [Chemical 9]
【0010】で示される基である上記(1)記載の化合
物またはその塩、(6)nが1〜5である上記(1)記
載の化合物またはその塩、および(7)nが2である上
記(6)記載の化合物またはその塩、(8)式(II): [式中、R1は、一般式(I)と同意義、R5は、ハロゲン
または式(III):The compound or salt thereof described in (1) above, which is a group represented by: (6) the compound or salt thereof described in (1) above, wherein n is 1 to 5, and (7) n is 2. The compound or salt thereof according to (6) above, (8) formula (II): [In the formula, R 1 has the same meaning as in the general formula (I), R 5 represents halogen or the formula (III):
【0011】 [0011]
【0012】(X5は、置換されていてもよい炭素数1
〜4の直鎖状または分枝状のアルキル基を示す。)で表
される置換基を示し、nは1〜10であり、[ ]内はす
べての立体異性体を含む。]で表される化合物と、式
(IV)(X 5 is an optionally substituted carbon atom 1
4 represents a linear or branched alkyl group. ) Represents a substituent, n is 1 to 10, and the inside of [] includes all stereoisomers. ] And the compound represented by Formula (IV)
【0013】[0013]
【化10】 [Chemical 10]
【0014】[式中、R2、R3およびR4は式(I)と同
意義であり、R3およびR4は一緒になってアセタールま
たはケタールを形成していてもよい。R6は、水素、ア
ルカリ金属またはアルカリ土類金属を示す。]で表され
る化合物を反応させることを特徴とする式(I):[In the formula, R 2 , R 3 and R 4 have the same meaning as in the formula (I), and R 3 and R 4 may together form an acetal or a ketal. R 6 represents hydrogen, an alkali metal or an alkaline earth metal. ] The compound (I) characterized by reacting the compound represented by:
【0015】[0015]
【化11】 [Chemical 11]
【0016】[式中、R1は、[Wherein R 1 is
【0017】[0017]
【化12】 [Chemical 12]
【0018】(X1およびX2は、同一または異なっ
て、アルキル基、ヒドロキシアルキル基、またはカルボ
キシル基を示す。)を示し、R2、R3およびR4は、同
一または異なって水素または有機残基を示す。また、R
3およびR4が一緒になってアセタールまたはケタールを
形成していてもよい。さらに、nは1〜10であり、
[ ]内は、すべての立体異性体を含む。]で表される化
合物の製造法に関する。(X 1 and X 2 are the same or different and each represents an alkyl group, a hydroxyalkyl group, or a carboxyl group), and R 2 , R 3 and R 4 are the same or different and are hydrogen or an organic group. Indicates a residue. Also, R
3 and R 4 may together form an acetal or ketal. Further, n is 1-10,
[] Includes all stereoisomers. ] The manufacturing method of the compound represented by these.
【0019】式(I)において、R2、R3およびR4で示
される有機残基としては、アルキル基、シクロアルキル
基、アルケニル基、アルキニル基、アラルキル基、アリ
ール基、ヘテロ環基、アシル基などが挙げられる。これ
らの基はそれぞれ、ハロゲン(例、塩素、臭素、ヨウ
素、フッ素など)、シアノ、ヒドロキシル、カルボキシ
ルまたはそのエステル、ニトロ、アミノカルボニル、C
1-22アシル(例、ホルミル、アセチル、プロピオニル、
ブチリル、ステアロイル、オレオイルなど)、C1-22ア
ルコキシ(例、メトキシ、エトキシ、プロポキシ、ブト
キシ、ヘキシルオキシなど)などの置換基を有していて
もよい。In the formula (I), the organic residue represented by R 2 , R 3 and R 4 is an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aralkyl group, an aryl group, a heterocyclic group or an acyl group. Groups and the like. Each of these groups is halogen (eg, chlorine, bromine, iodine, fluorine, etc.), cyano, hydroxyl, carboxyl or its ester, nitro, aminocarbonyl, C
1-22 acyl (eg formyl, acetyl, propionyl,
It may have a substituent such as butyryl, stearoyl, oleoyl), C 1-22 alkoxy (eg, methoxy, ethoxy, propoxy, butoxy, hexyloxy, etc.) and the like.
【0020】R2、R3およびR4で示される有機残基と
して例示されるアルキル基としては、直鎖状または分枝
状の炭素数1〜22のアルキル基が好ましく、さらに炭
素数1〜10のものが好ましく、とりわけ炭素数1〜5
のものが好ましい。その具体例としては、メチル、エチ
ル、n−プロピル、iso−プロピル、n−ブチル、sec−ブ
チル、tert−ブチル、n−ペンチル、iso−アミル、tert
−アミル、n−ヘキシル、n−ヘプチル、n−オクチル、n
−ノニル、n−デシル、n−ウンデシル、n−ドデシル、n
−トリデシル、n−テトラデシル、n−ペンタデシル、n
−ヘキサデシル、 n−ヘプタデシル、n−オクタデシ
ル、n−エイコシル、n−ドコシル、n−テトラコシル、n
−ペンタコシルなどが挙げられる。The alkyl group exemplified as the organic residue represented by R 2 , R 3 and R 4 is preferably a linear or branched alkyl group having 1 to 22 carbon atoms, more preferably 1 to 22 carbon atoms. 10 are preferred, especially 1 to 5 carbon atoms
Are preferred. Specific examples thereof include methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, tert-butyl, n-pentyl, iso-amyl, tert.
-Amyl, n-hexyl, n-heptyl, n-octyl, n
-Nonyl, n-decyl, n-undecyl, n-dodecyl, n
-Tridecyl, n-tetradecyl, n-pentadecyl, n
-Hexadecyl, n-heptadecyl, n-octadecyl, n-eicosyl, n-docosyl, n-tetracosyl, n
-Pentacosyl and the like.
【0021】R2、R3およびR4で示される有機残基と
して例示されるシクロアルキル基としては、炭素数3〜
8、好ましくは5〜7のものが挙げられる。その例とし
ては、シクロプロピル、シクロブチル、シクロペンチ
ル、シクロヘキシル、シクロヘプチル、シクロオクチル
などが挙げられる。The cycloalkyl group exemplified as the organic residue represented by R 2 , R 3 and R 4 has 3 to 10 carbon atoms.
8, preferably 5 to 7. Examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and the like.
【0022】R2、R3およびR4で示される有機残基と
して例示されるアルケニル基としては、炭素数2〜2
2、好ましくは2〜10のものが挙げられる。その例と
しては、ビニル、プロペニル、ブテニル、ペンテニル、
ヘプテニル、ノニル、ウンデセニル、トリデセニル、ペ
ンタデセニル、ヘプタデセニル、ノナデセニル、エイコ
セニルなどが挙げられる。The alkenyl group exemplified as the organic residue represented by R 2 , R 3 and R 4 has 2 to 2 carbon atoms.
2, preferably 2 to 10. Examples are vinyl, propenyl, butenyl, pentenyl,
Heptenyl, nonyl, undecenyl, tridecenyl, pentadecenyl, heptadecenyl, nonadecenyl, eicosenyl and the like can be mentioned.
【0023】R2、R3およびR4で示される有機残基と
して例示されるアルキニル基としては、炭素数2〜2
2、好ましくは2〜10のものが挙げられる。具体的に
は、エチニル、プロピニル、ブチニル、ヘキシニル、オ
クチニル、ノニニル、デシニル、ドデシニル、テトラデ
シニル、ヘプタデシニル、オクタデシニル、エイコデシ
ニルなどが挙げられる。The alkynyl group exemplified as the organic residue represented by R 2 , R 3 and R 4 has 2 to 2 carbon atoms.
2, preferably 2 to 10. Specific examples include ethynyl, propynyl, butynyl, hexynyl, octynyl, nonynyl, decynyl, dodecynyl, tetradecynyl, heptadecynyl, octadecynyl, eicodecynyl and the like.
【0024】R2、R3およびR4で示される有機残基と
して例示されるアラルキル基としては、炭素数6〜1
4、好ましくは炭素数6〜8のアリールと炭素数1〜
6、好ましくは1〜3のアルキル基よりなるものが挙げ
られる。具体的には、ベンジル、フェニルエチル、メチ
ルベンジル、ナフチルメチルなどが挙げられる。The aralkyl group exemplified as the organic residue represented by R 2 , R 3 and R 4 has 6 to 1 carbon atoms.
4, preferably aryl having 6 to 8 carbon atoms and 1 to carbon atoms
Those having an alkyl group of 6, preferably 1 to 3 are mentioned. Specific examples include benzyl, phenylethyl, methylbenzyl, naphthylmethyl and the like.
【0025】R2、R3およびR4で示される有機残基と
して例示されるアリール基としては、炭素数6〜14、
好ましくは炭素数6〜8のもの、具体的には、フェニ
ル、ナフチルなどが挙げられる。該アリール基は、置換
されていてもよく、その置換基は、上記置換基[すなわ
ちハロゲン(例、塩素、臭素、ヨウ素、フッ素など)、
シアノ、ヒドロキシル、カルボキシルまたはそのエステ
ル、ニトロ、アミノカルボニル、C1-22アシル(例、ホ
ルミル、アセチル、プロピオニル、ブチリル、ステアロ
イル、オレオイルなど)、C1-22アルコキシ(例、メト
キシ、エトキシ、プロポキシ、ブトキシ、ヘキシルオキ
シなど)]のほか、例えばそれぞれ上記したアルキル
基、アルケニル基およびアルキニル基から選ばれる。置
換基は該アリール基の環の置換可能ないずれの位置にあ
ってもよい。The aryl group exemplified as the organic residue represented by R 2 , R 3 and R 4 has 6 to 14 carbon atoms,
Preferred are those having 6 to 8 carbon atoms, specifically phenyl, naphthyl and the like. The aryl group may be substituted, and the substituent is the above-mentioned substituent [that is, halogen (eg, chlorine, bromine, iodine, fluorine, etc.),
Cyano, hydroxyl, carboxyl or its ester, nitro, aminocarbonyl, C 1-22 acyl (eg, formyl, acetyl, propionyl, butyryl, stearoyl, oleoyl etc.), C 1-22 alkoxy (eg, methoxy, ethoxy, propoxy). , Butoxy, hexyloxy, etc.)], for example, selected from the above-mentioned alkyl group, alkenyl group and alkynyl group. The substituent may be at any substitutable position on the ring of the aryl group.
【0026】R2、R3およびR4で示される有機残基と
して例示されるヘテロ環基は、環構成原子として窒素、
酸素および硫黄から選ばれる少なくとも1個のヘテロ原
子を含有する5〜7員環基を意味し、芳香族ヘテロ環基
および非芳香族ヘテロ環基の双方を包含する。芳香族ヘ
テロ環基としては、例えばピリジル、テトラゾリル、フ
リル、チエニルなどが挙げられる。非芳香族ヘテロ環基
としては、例えばテトラヒドロフラニル、ジヒドロピラ
ニルなどが挙げられる。該ヘテロ環基は、上記アリール
基の置換基と同様の基および位置で置換されていてもよ
い。The heterocyclic group exemplified as the organic residue represented by R 2 , R 3 and R 4 is nitrogen as a ring-constituting atom,
It means a 5- to 7-membered ring group containing at least one hetero atom selected from oxygen and sulfur, and includes both aromatic heterocyclic groups and non-aromatic heterocyclic groups. Examples of the aromatic heterocyclic group include pyridyl, tetrazolyl, furyl, thienyl and the like. Examples of the non-aromatic heterocyclic group include tetrahydrofuranyl, dihydropyranyl and the like. The heterocyclic group may be substituted with the same group and position as the above-mentioned substituent of the aryl group.
【0027】R2、R3およびR4で示される有機残基と
して例示されるアシル基としては、炭素数1〜22、好
ましくは炭素数1〜8のものが挙げられる。具体的に
は、ホルミル、アセチル、プロピオニル、ブチリル、イ
ソブチリル、バレリル、イソバレリル、ピバロイル、ヘ
キサノイル、ヘプタノイル、オタクノイル、ノナノイ
ル、デカノイル、ウラロイル、ミリストイル、パルミト
イル、ステアロイル、ベンゾイルが挙げられる。The acyl group exemplified as the organic residue represented by R 2 , R 3 and R 4 includes those having 1 to 22 carbon atoms, preferably 1 to 8 carbon atoms. Specific examples include formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, pivaloyl, hexanoyl, heptanoyl, otakunoyl, nonanoyl, decanoyl, uraloyl, myristoyl, palmitoyl, stearoyl, benzoyl.
【0028】さらに、R3およびR4が一緒になってアセ
タール残基またはケタール残基を形成していてもよい。
この場合、R3およびR4は、式(V):Further, R 3 and R 4 may together form an acetal residue or a ketal residue.
In this case, R 3 and R 4 have the formula (V):
【0029】[0029]
【化13】 [Chemical 13]
【0030】[式中、X3およびX4は、同一または異な
って、水素原子、アルキル基または置換されていてもよ
いフェニル基を示す]で表される。X3またはX4で示さ
れるアルキル基としては、上記R2で示されるアルキル
基と同様のものが挙げられる。このうちメチルおよびエ
チルが好ましい。X3で示される置換されていてもよい
フェニル基の置換基としては、上記R2で示されるアリ
ール基の置換基と同様のものが挙げられる。このうちp
−メトキシ基が好ましい。本発明においては、X3およ
びX4がメチル基である場合が好ましい。[Wherein X 3 and X 4 are the same or different and each represents a hydrogen atom, an alkyl group or an optionally substituted phenyl group]. Examples of the alkyl group represented by X 3 or X 4 include those similar to the alkyl group represented by R 2 above. Of these, methyl and ethyl are preferred. Examples of the substituent of the optionally substituted phenyl group represented by X 3 include the same as the substituents of the aryl group represented by R 2 . Of these, p
-Methoxy group is preferred. In the present invention, it is preferred that X 3 and X 4 are methyl groups.
【0031】また、nは1〜10の範囲、好ましくは1
〜5の範囲であり、[ ]内は、すべての立体異性体を含
む。Further, n is in the range of 1 to 10, preferably 1
Is in the range of to 5, and [] includes all stereoisomers.
【0032】本発明の式(I)で表される化合物は、式(I
I): [式中、R1は、一般式(I)と同意義、R5は、ハロゲン
(例、フッ素、塩素、臭素、ヨウ素)または式(II
I):The compound represented by the formula (I) of the present invention has the formula (I)
I): [In the formula, R 1 has the same meaning as in the general formula (I), R 5 represents halogen (eg, fluorine, chlorine, bromine, iodine) or the formula (II
I):
【0033】 [0033]
【0034】(X5は、置換されていてもよい炭素数1
〜4の直鎖状または分枝状のアルキル基(例、メチル
基、トリフルオロメチル基、エチル基など)を示す。)
で表される置換基を示し、nは1〜10、好ましくは1
〜5であり、[ ]内はすべての立体異性体を含む。]で
表される化合物と、式(IV)(X 5 is an optionally substituted carbon atom 1
4 represents a linear or branched alkyl group (eg, methyl group, trifluoromethyl group, ethyl group, etc.). )
Represents a substituent represented by, n is 1 to 10, preferably 1
~ 5, and [] includes all stereoisomers. And a compound represented by the formula (IV)
【0035】[0035]
【化14】 [Chemical 14]
【0036】[式中、R2、R3およびR4は式(I)と同意
義であり、R3およびR4は一緒になって上記式(V)で
表されるアセタールまたはケタールを形成していてもよ
い。R6は、水素、アルカリ金属(例、リチウム、ナト
リウム、カリウムなど)またはアルカリ土類金属(例、
マグネシウム、カルシウムなど)を示す。]で表される
化合物を反応させることによって製造することができ
る。[Wherein R 2 , R 3 and R 4 have the same meaning as in formula (I), and R 3 and R 4 together form an acetal or ketal represented by the above formula (V). You may have. R 6 is hydrogen, an alkali metal (eg, lithium, sodium, potassium, etc.) or an alkaline earth metal (eg,
Magnesium, calcium, etc.). ] It can manufacture by making the compound represented by these react.
【0037】式(IV)で表される化合物の使用量は、式(I
I)で表される化合物に対して0.5当量以上、好ましく
は、0.5〜3当量である。反応溶媒としては、反応を
阻害しない物であれば特に制限はないが、好ましくは、
ハロゲン化炭化水素類(例、塩化メチレン、クロロホル
ム)、エーテル類(例、ジオキサン、テトラヒドロフラ
ン、1,2−ジメトキシエタンなど)、ジメチルホルム
アミドなどが用いられる。これらの溶媒は、単独または
混合して使用することができる。さらに、必要に応じ
て、ピリジン、コリジン、ルチジン、トリエチルアミ
ン、ジイソプロピルエチルアミン等の三級アミンを塩基
として反応溶媒に加えてもよい。反応温度は、−50℃
〜100℃であり、好ましくは、20℃〜50℃であ
る。反応時間は、0.5時間〜30時間程度である。本
反応によって得られる化合物は、常法により反応溶媒を
除去後、再結晶、再沈澱、カラムクロマトグラフィーな
どの一般的な方法によって精製される。この方法によっ
て得られる化合物の置換基を、一般的な方法によって修
飾し、式(I)に包含される化合物に変換してもよい。The amount of the compound represented by the formula (IV) used is
It is 0.5 equivalents or more, preferably 0.5 to 3 equivalents, relative to the compound represented by I). The reaction solvent is not particularly limited as long as it does not inhibit the reaction, but preferably,
Halogenated hydrocarbons (eg methylene chloride, chloroform), ethers (eg dioxane, tetrahydrofuran, 1,2-dimethoxyethane etc.), dimethylformamide and the like are used. These solvents can be used alone or in combination. Further, if necessary, a tertiary amine such as pyridine, collidine, lutidine, triethylamine and diisopropylethylamine may be added as a base to the reaction solvent. Reaction temperature is -50 ° C
To 100 ° C, preferably 20 ° C to 50 ° C. The reaction time is about 0.5 to 30 hours. The compound obtained by this reaction is purified by a general method such as recrystallization, reprecipitation or column chromatography after removing the reaction solvent by a conventional method. The substituents on the compounds obtained by this method may be modified by conventional methods and converted to compounds covered by formula (I).
【0038】上記反応において原料として用いた式(II)
で表される化合物は、公知方法により製造することがで
きる。例えば、下記実施例1および実施例2−1で原料
として使用するレチノイル フルオライドは、アルン・
ビー・バルア(Arun B.Barua)およびジェイムズ・エイ
・オルソン(James A. Olson)、バイオキミカ・エト・
バイオフィジイカ・アクタ(Biochimica et Biophysic
a Acta)757,288−295(1983)にて報告さ
れている方法で製造される。また、式(IV)で表される化
合物も、公知方法により製造することができる。例え
ば、下記実施例1で原料として使用するL−アスコルビ
ン酸 5,6−アセトナイドは、チャン・チェン・ウェイ
(Chung Chen Wei)ら、ジャーナル・オブ・オーガニッ
ク・ケミストリー(Journal of Organic Chemistry),5
0,3462−3467(1985)にて報告されている
方法で製造される。Formula (II) used as a raw material in the above reaction
The compound represented by can be produced by a known method. For example, retinoyl fluoride used as a raw material in Examples 1 and 2-1 below is
Arun B. Barua and James A. Olson, Bio Kimika Eto
Biochijica et Biophysic
a Acta) 757 , 288-295 (1983). Further, the compound represented by the formula (IV) can also be produced by a known method. For example, L-ascorbic acid 5,6-acetonide used as a raw material in Example 1 below can be obtained from Chung Chen Wei et al., Journal of Organic Chemistry, 5.
0, it is prepared by methods which are reported in 3462-3467 (1985).
【0039】本発明の式(I)で表される化合物は、抗酸
化作用を有し、例えば食品用の抗酸化剤として有用であ
る。The compound represented by the formula (I) of the present invention has an antioxidant action and is useful as an antioxidant for foods, for example.
【0040】[0040]
【実施例】以下、実施例を挙げて本発明をさらに詳しく
説明するが、本発明はこれらに限定されるものではな
い。 実施例1 3−レチノイル L−アスコルビン酸 5,6−アセト
ナイド L−アスコルビン酸 5,6−アセトナイド453mg(2.
1mmol)のピリジン溶液3mlにレチノイル フルオライド
290mg(0.96mmol)の塩化メチレン溶液7mlを加
え、室温で15時間撹拌して反応する。反応液を酢酸エ
チルで希釈し、希塩酸および水で順次洗浄する。無水硫
酸ナトリウムにて乾燥後、溶媒を留去して得られた残渣
を、カラムクロマトグラフィー(シリカゲル、溶出液
酢酸エチル:ヘキサン=2:3)により精製して3−レチ
ノイル L−アスコルビン酸 5,6−アセトナイド28
0mg(収率59%)が黄色油状物質として得られた。得ら
れた化合物は、抗酸化性を示した。 MS m/z:498.263(M+,C29H38O7) IR(CHCl3)cm-1:3540、3280、1780、
1720(sh)、1705、1600、1565 UV(EtOH)λ:365nm1 H−NMR(CDCl3)δ:1.04(6H,s,1'−gem−
Me)、1.37,1.40(それぞれ3H,s,OCMe2C
O)、1.73(3H,s,5'−Me)、2.05(3H,s,9'
−Me)、2.44(3H,s,13'−Me)、4.07,4.1
8(それぞれ1H,dd,J=8,7Hz,6−H2)、4.35
(1H,td,J=7,2.5Hz,5−H)、4.75(1H,d,
J=2.5Hz,4−H)、5.88(1H,br s,14'−
H)、6.19(1H,d,J=16Hz,8'−H)、6.20
(1H,br d,J=11.5Hz, 10'−H)、6.35(1
H,d,J=15Hz,12'−H)、6.41(1H,br d,J
=16Hz,7'−H)、7.22(1H,dd,J=15,11.
5Hz,11'−H)、7.94(1H,br s,2−OH)The present invention will be described in more detail below with reference to examples, but the present invention is not limited thereto. Example 1 3-retinoyl L-ascorbic acid 5,6-acetonide L-ascorbic acid 5,6-acetonide 453 mg (2.
To 3 ml of a pyridine solution of 1 mmol) was added 7 ml of a methylene chloride solution of 290 mg (0.96 mmol) of retinoyl fluoride, and the mixture was stirred at room temperature for 15 hours for reaction. The reaction solution is diluted with ethyl acetate and washed successively with diluted hydrochloric acid and water. After drying over anhydrous sodium sulfate, the solvent was distilled off and the resulting residue was subjected to column chromatography (silica gel, eluent).
Ethyl acetate: hexane = 2: 3) to give 3-retinoyl L-ascorbic acid 5,6-acetonide 28
0 mg (59% yield) was obtained as a yellow oil. The resulting compound exhibited antioxidant properties. MS m / z: 498.263 (M + , C 29 H 38 O 7 ) IR (CHCl 3 ) cm −1 : 3540, 3280, 1780,
1720 (sh), 1705, 1600, 1565 UV (EtOH) λ: 365 nm 1 H-NMR (CDCl 3 ) δ: 1.04 (6 H, s, 1'-gem-
Me), 1.37, 1.40 (3H, s, OCMe 2 C respectively)
O), 1.73 (3H, s, 5'-Me), 2.05 (3H, s, 9 '
-Me), 2.44 (3H, s, 13'-Me), 4.07, 4.1
8 (each 1H, dd, J = 8,7Hz, 6-H 2), 4.35
(1H, td, J = 7,2.5Hz, 5-H), 4.75 (1H, d,
J = 2.5 Hz, 4-H), 5.88 (1 H, br s, 14'-
H), 6.19 (1H, d, J = 16Hz, 8'-H), 6.20
(1H, brd, J = 11.5Hz, 10'-H), 6.35 (1
H, d, J = 15Hz, 12'-H), 6.41 (1H, brd, J
= 16 Hz, 7'-H), 7.22 (1H, dd, J = 15,11.
5Hz, 11'-H), 7.94 (1H, brs, 2-OH)
【0041】実施例2−1 3−レチノイル L−アスコルビン酸 レチノイル フルオライド304mg(1.01mmol)および
L−アスコルビン酸ナトリウム304mg(1.54mmol)
のジメチルホルムアミド溶液7mlを室温で1時間撹拌反
応する。反応液を酢酸エチルで希釈し、水洗後、無水硫
酸ナトリウムにて乾燥した。溶媒を留去して得られた残
渣をカラムクロマトグラフィー(コスモシル(Cosmosil)
140C18−OPN、溶出液 テトラヒドロフラン:ア
セトニトリル=1:9)を用いて精製し、3−レチノイル
L−アスコルビン酸396mg(収率86%)を淡黄色結
晶として得た。得られた化合物は、抗酸化性を示した。 MS m/z:458.231(M+,C26H34O7) IR(CHCl3)cm-1:3600−3150、1775、
1720、1705、1600、1565 UV(EtOH)λ:365nm1 H−NMR(CDCl3)δ:1.04(6H,s,1'−gem−
Me)、1.73(3H,s,5'−Me)、2.05(3H,s,9'
−Me)、2.43(3H,s,13'−Me)、3.83(1H,d
d,J=11.5Hz,6−H)、3.89(1H,dd,J=1
1.6Hz,6−H)、4.00(1H,m,5−H)、4.90
(1H,d,J=2Hz,4−H)、5.88(1H,br s,14'
−H)、6.18(1H,d,J=16Hz,8'−H)、6.1
9(1H, br d,J=11.5Hz,10'−H)、6.34
(1H,d,J=15Hz,12'−H)、6.39(1H,br d,
J=16Hz,7'−H)、7.21(1H,dd,J=15,1
1.5Hz、11'−H)、7.80−8.10(1H,br,O
H).Example 2-1 3-retinoyl L-ascorbate Retinoyl fluoride 304 mg (1.01 mmol) and sodium L-ascorbate 304 mg (1.54 mmol)
7 ml of the dimethylformamide solution of 1 is reacted with stirring at room temperature for 1 hour. The reaction solution was diluted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate. The residue obtained by distilling off the solvent was subjected to column chromatography (Cosmosil).
140C 18 -opn, eluent tetrahydrofuran: acetonitrile = 1: 9) as eluant to afford 3-retinoyl L- ascorbic acid 396mg (86% yield) as pale yellow crystals. The resulting compound exhibited antioxidant properties. MS m / z: 458.231 (M +, C 26 H 34 O 7) IR (CHCl 3) cm -1: 3600-3150,1775,
1720, 1705, 1600, 1565 UV (EtOH) λ: 365 nm 1 H-NMR (CDCl 3 ) δ: 1.04 (6H, s, 1′-gem-
Me), 1.73 (3H, s, 5'-Me), 2.05 (3H, s, 9 '
-Me), 2.43 (3H, s, 13'-Me), 3.83 (1H, d
d, J = 11.5Hz, 6-H), 3.89 (1H, dd, J = 1)
1.6 Hz, 6-H), 4.00 (1 H, m, 5-H), 4.90
(1H, d, J = 2Hz, 4-H), 5.88 (1H, brs, 14 '
-H), 6.18 (1H, d, J = 16Hz, 8'-H), 6.1
9 (1H, brd, J = 11.5Hz, 10'-H), 6.34
(1H, d, J = 15Hz, 12'-H), 6.39 (1H, br d,
J = 16Hz, 7'-H), 7.21 (1H, dd, J = 15,1)
1.5Hz, 11'-H), 7.80-8.10 (1H, br, O
H).
【0042】実施例2−2 3−レチノイル L−アスコルビン酸 実施例1で得られた3−レチノイル L−アスコルビン
酸 5,6−アセトナイド280mgをテトラヒドロフラ
ン:メタノール=3:1の溶液4mlに溶解後、2N塩酸
1.2mlを加え、50℃で1.5時間撹拌反応を行った。
反応液を酢酸エチルで希釈し、水洗後、無水硫酸ナトリ
ウムで乾燥した。溶媒を留去後、得られた残渣を薄層ク
ロマトグラフィー(RP−18、メルク(Merck)Art.1
5389、溶媒、テトラヒドロフラン:アセトニトリル
=1:9)を用いて精製して、3−レチノイル L−アス
コルビン酸76mg(収率70%)を淡黄色結晶として得
た。得られた化合物は、抗酸化性を示した。 MS m/z:458.231(M+,C26H34O7) IR(CHCl3)cm-1:3600−3150、1775、
1720、1705、1600、1565 UV(EtOH)λ:365nm1 H−NMR(CDCl3)δ:1.04(6H,s,1'−gem−
Me)、1.73(3H,s,5'−Me)、2.05(3H,s,9'
−Me)、2.43(3H,s,13'−Me)、3.83(1H,d
d,J=11.5Hz,6−H)、3.89(1H,dd,J=11.
6Hz,6−H)、4.00(1H,m,5−H)、4.90(1
H,d,J=2Hz,4−H)、5.88(1H, br s,14'−
H)、6.18(1H,d,J=16Hz,8'−H)、6.19
(1H,br d,J=11.5Hz,10'−H)、6.34(1
H,d,J=15Hz,12'−H)、6.39(1H,br d,J
=16Hz,7'−H)、7.21(1H,dd,J=15,11.
5Hz,11'−H)、7.80−8.10(1H,br,OH).Example 2-2 3-retinoyl L-ascorbic acid 280 mg of 3-retinoyl L-ascorbic acid 5,6-acetonide obtained in Example 1 was dissolved in 4 ml of a solution of tetrahydrofuran: methanol = 3: 1. 1.2 ml of 2N hydrochloric acid was added and the reaction was carried out at 50 ° C. for 1.5 hours with stirring.
The reaction solution was diluted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate. After evaporation of the solvent, the residue obtained was subjected to thin layer chromatography (RP-18, Merck Art. 1).
Purification using 5389, solvent, tetrahydrofuran: acetonitrile = 1: 9) gave 76 mg (yield 70%) of 3-retinoyl L-ascorbic acid as pale yellow crystals. The resulting compound exhibited antioxidant properties. MS m / z: 458.231 (M +, C 26 H 34 O 7) IR (CHCl 3) cm -1: 3600-3150,1775,
1720, 1705, 1600, 1565 UV (EtOH) λ: 365 nm 1 H-NMR (CDCl 3 ) δ: 1.04 (6H, s, 1′-gem-
Me), 1.73 (3H, s, 5'-Me), 2.05 (3H, s, 9 '
-Me), 2.43 (3H, s, 13'-Me), 3.83 (1H, d
d, J = 11.5 Hz, 6-H), 3.89 (1 H, dd, J = 11.
6Hz, 6-H), 4.00 (1H, m, 5-H), 4.90 (1
H, d, J = 2Hz, 4-H), 5.88 (1H, brs, 14'-
H), 6.18 (1H, d, J = 16Hz, 8'-H), 6.19
(1H, brd, J = 11.5Hz, 10'-H), 6.34 (1
H, d, J = 15 Hz, 12'-H), 6.39 (1H, br d, J
= 16 Hz, 7'-H), 7.21 (1H, dd, J = 15,11.
5Hz, 11'-H), 7.80-8.10 (1H, br, OH).
【0043】[0043]
【発明の効果】本発明によれば、食品用の抗酸化剤など
として有用な新規化合物である、レチノイドとアスコル
ビン酸からなるエステル化合物およびその誘導体ならび
にそれらの製造法が提供される。INDUSTRIAL APPLICABILITY According to the present invention, there are provided a novel compound useful as an antioxidant for foods and the like, an ester compound comprising retinoid and ascorbic acid, a derivative thereof and a method for producing them.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 日下 博昭 兵庫県宝塚市安倉南3丁目3番 1−202 号 (72)発明者 山本 佳弘 兵庫県伊丹市荻野8丁目21番地の2 ハイ ツマインド203号 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Hiroaki Kusaka 3-chome 1-32 Akura Minami, Takarazuka City, Hyogo Prefecture 1-202 (72) Inventor Yoshihiro Yamamoto 8-21 21 Ogino City, Itami City, Hyogo Prefecture 203 High Mind 203 issue
Claims (8)
ヒドロキシアルキル基、またはカルボキシル基を示
す。)を示し、R2、R3およびR4は、同一または異な
って水素または有機残基を示す。また、R3およびR4が
一緒になってアセタールまたはケタールを形成していて
もよい。さらに、nは1〜10であり、[ ]内は、すべ
ての立体異性体を含む。]で表される化合物またはその
塩。1. Formula (I): [Wherein R 1 is (X 1 and X 2 are the same or different and are an alkyl group,
A hydroxyalkyl group or a carboxyl group is shown. ) And R 2 , R 3 and R 4 are the same or different and each represents hydrogen or an organic residue. Further, R 3 and R 4 may be taken together to form an acetal or a ketal. Furthermore, n is 1 to 10, and the inside of [] includes all stereoisomers. ] The compound or its salt represented by these.
1記載の化合物またはその塩。2. The compound according to claim 1, wherein R 2 , R 3 and R 4 are hydrogen, or a salt thereof.
れていてもよいアルキル基、シクロアルキル基、アルケ
ニル基、アルキニル基、アラルキル基、アリール基、ヘ
テロ環基またはアシル基から選ばれる有機残基である請
求項1記載の化合物またはその塩。3. R 2 , R 3 and R 4 are each selected from an optionally substituted alkyl group, cycloalkyl group, alkenyl group, alkynyl group, aralkyl group, aryl group, heterocyclic group or acyl group. The compound or salt thereof according to claim 1, which is an organic residue.
メチル基、ヒドロキシメチル基またはカルボキシル基で
ある請求項1記載の化合物またはその塩。4. X 1 and X 2 are the same or different,
The compound or a salt thereof according to claim 1, which is a methyl group, a hydroxymethyl group or a carboxyl group.
塩。5. R 1 is The compound or salt thereof according to claim 1, which is a group represented by:
またはその塩。6. The compound according to claim 1, wherein n is 1 to 5, or a salt thereof.
はその塩。7. The compound according to claim 6, wherein n is 2, or a salt thereof.
または式(III): (X5は、置換されていてもよい炭素数1〜4の直鎖状
または分枝状のアルキル基を示す。)で表される置換基
を示し、nは1〜10であり、[ ]内はすべての立体異
性体を含む。]で表される化合物と、式(IV) 【化4】 [式中、R2、R3およびR4は式(I)と同意義であり、R
3およびR4は一緒になってアセタールまたはケタールを
形成していてもよい。R6は、水素、アルカリ金属また
はアルカリ土類金属を示す。]で表される化合物を反応
させることを特徴とする式(I): 【化5】 [式中、R1は、 【化6】 (X1およびX2は、同一または異なって、アルキル
基、ヒドロキシアルキル基、またはカルボキシル基を示
す。)を示し、R2、R3およびR4は、同一または異な
って水素または有機残基を示す。また、R3およびR4が
一緒になってアセタールまたはケタールを形成していて
もよい。さらに、nは1〜10であり、[ ]内は、すべ
ての立体異性体を含む。]で表される化合物の製造法。8. Formula (II): [In the formula, R 1 has the same meaning as in the general formula (I), R 5 represents halogen or the formula (III): (X 5 represents an optionally substituted linear or branched alkyl group having 1 to 4 carbon atoms), n is 1 to 10, and [] The term includes all stereoisomers. ] And a compound of formula (IV) [Wherein R 2 , R 3 and R 4 have the same meanings as in formula (I),
3 and R 4 may together form an acetal or ketal. R 6 represents hydrogen, an alkali metal or an alkaline earth metal. ] The compound represented by the formula (I) characterized by reacting: [Wherein R 1 is (X 1 and X 2 are the same or different and represent an alkyl group, a hydroxyalkyl group, or a carboxyl group), and R 2 , R 3 and R 4 are the same or different and each represent a hydrogen atom or an organic residue. Show. Further, R 3 and R 4 may be taken together to form an acetal or a ketal. Furthermore, n is 1 to 10, and the inside of [] includes all stereoisomers. ] The manufacturing method of the compound represented by these.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5291801A JPH07138248A (en) | 1993-11-22 | 1993-11-22 | Ester compound from retinoid and ascorbic acid and derivative therefrom and their production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5291801A JPH07138248A (en) | 1993-11-22 | 1993-11-22 | Ester compound from retinoid and ascorbic acid and derivative therefrom and their production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07138248A true JPH07138248A (en) | 1995-05-30 |
Family
ID=17773608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5291801A Pending JPH07138248A (en) | 1993-11-22 | 1993-11-22 | Ester compound from retinoid and ascorbic acid and derivative therefrom and their production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07138248A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002092600A1 (en) * | 2001-05-15 | 2002-11-21 | Ardenia Investments Ltd. | Retinol derivatives potentiation of active substances by micellar preparation |
KR100399348B1 (en) * | 1998-03-27 | 2004-03-22 | 주식회사 엘지생명과학 | Polyethoxylated vitamin c derivative and method for manufacturing the same |
JP2009035509A (en) * | 2007-08-01 | 2009-02-19 | Green Products Laboratory Ltd | Ascorbic acid ester and synthesis method thereof |
EP3092220A4 (en) * | 2013-09-25 | 2017-08-30 | University of Florida Research Foundation, Inc. | Vitamin c prodrugs and uses thereof |
CN117466845A (en) * | 2023-08-07 | 2024-01-30 | 上海克琴科技有限公司 | An ester compound and its use |
-
1993
- 1993-11-22 JP JP5291801A patent/JPH07138248A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100399348B1 (en) * | 1998-03-27 | 2004-03-22 | 주식회사 엘지생명과학 | Polyethoxylated vitamin c derivative and method for manufacturing the same |
WO2002092600A1 (en) * | 2001-05-15 | 2002-11-21 | Ardenia Investments Ltd. | Retinol derivatives potentiation of active substances by micellar preparation |
JP2009035509A (en) * | 2007-08-01 | 2009-02-19 | Green Products Laboratory Ltd | Ascorbic acid ester and synthesis method thereof |
EP3092220A4 (en) * | 2013-09-25 | 2017-08-30 | University of Florida Research Foundation, Inc. | Vitamin c prodrugs and uses thereof |
CN117466845A (en) * | 2023-08-07 | 2024-01-30 | 上海克琴科技有限公司 | An ester compound and its use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1200384B1 (en) | 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production | |
DE2539963C2 (en) | Purine compounds, processes for their preparation and pharmaceutical preparations containing these compounds | |
EP0298452A2 (en) | 2H-1-benzopyrane derivatives substituted in position 4 by aryl or N-heteroaryl | |
EP0373423A1 (en) | Substituted 2-pyridones and pyride-2-thiones, process for their preparation and their use in medicine | |
WO1994013295A1 (en) | Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds | |
US4464361A (en) | Adenosine derivatives | |
JPH07138248A (en) | Ester compound from retinoid and ascorbic acid and derivative therefrom and their production | |
HU178302B (en) | Process for producing n-amidino-3,5-diamino-6-substituted-2-piperazine-carboxamides | |
EP1198458B1 (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
DE1620733A1 (en) | Azetidinothiazolidine methane carboxylic acid esters | |
KR880000704B1 (en) | Preparation process for glylosidex | |
JPH0121146B2 (en) | ||
DE3632893A1 (en) | 4-(R)-Hydroxy-6-(S)-arylthiomethyltetrahydropyran-2-ones, their corresponding sulphoxides and sulphones, processes for their preparation, their use as medicaments, pharmaceutical preparations and intermediates | |
JPH0560478B2 (en) | ||
EP0246534B1 (en) | Optically pure 4,5-disubstituted gamma-butyrolactame enantiomers, process for their preparation and their use | |
US3665015A (en) | Process for preparing 3-hydroxy-2-methyl-4-pyrone | |
JPH0931092A (en) | Process for producing 2'-3'-di-O-acyl ATP | |
EP0049144B1 (en) | 5-fluoro uracil derivatives | |
EP0040433B1 (en) | Nicotinic derivatives of glucosamine, process for their preparation and related pharmaceutical compositions | |
SU1745122A3 (en) | Method of saccharoascorbic acid ester synthesis | |
US5449684A (en) | Cytotoxic compounds | |
KR910006983B1 (en) | Process for the preparation of pyridine derivatives | |
US2414783A (en) | Pyridones and process for making them | |
EP0133670A2 (en) | Process for the preparation of 7-acylamino-3-hydroxy-cephem-4-carboxylic acids and 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylic acids | |
US4156728A (en) | 3-Substituted-2(1H)pyridone-6-carboxylic acids |